Hepatic Sarcoidosis and Spondyloarthritis Overlap: Efficacy and Safety of TNF Inhibitors - A Case Report
The diagnosis of spondyloarthritis should be considered in patients with sarcoidosis who present with low back pain or pygalgia. The coexistence of spondyloarthritis and sarcoidosis, further complicated by hepatic cirrhosis and portal hypertension, presents significant therapeutic challenges. This case report suggests that adalimumab is an effective and safe treatment option for patients with spondyloarthritis and sarcoidosis associated with cirrhosis.
Authors
- W. Lahmar (ORCID: https://orcid.org/0000-0002-0948-6719)
- I. Mejri (ORCID: https://orcid.org/0000-0002-8296-4182)
- Z. Moatamri
- Samar Zarati (ORCID: https://orcid.org/0009-0006-5807-3431)
- Nada Mansouri
- Imen Gharsallah
- Maroua Slouma
Institutions
- Hôpital La Rabta (TN)
- Military Hospital of Tunis (TN)
- Tunis El Manar University (TN)
Publication Details
- Journal
- Current Rheumatology Reviews
- Published
- 2026-01-02
- DOI
- https://doi.org/10.2174/0115733971430514251113112320
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00